Phillip J. Robinson
214 Hawkesbury Rd
Westmead, NSW 2145, Australia
Westmead, NSW 2145, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 120 publications
Sulfonadyn Compounds: A Class of Aryl Sulfonamides That Inhibit Dynamin GTPase and Clathrin-Mediated Endocytosis and Are Antiepileptic in Animal Models.
Journal: ACS chemical biology
Published: June 18, 2026
Shared dysregulation of complement and phosphorylation pathways in the cerebrospinal fluid of encephalitis, Aicardi-Goutières syndrome, and autism.
Journal: Developmental medicine and child neurology
Published: March 23, 2026
Potential treatment targets in the whole-tissue proteome of triple negative breast cancer.
Journal: NPJ breast cancer
Published: February 12, 2026
DFT guided design of novel quinone bioisosteres as inhibitors of the clathrin N-terminal domain-amphiphysin protein-protein interaction. Dihydroquinazolin-4(1H)-ones and quinazolin-3(4H)-ones.
Journal: European journal of medicinal chemistry
Published: January 15, 2026
Modeling Synaptic Maturation From Growth Cone to Synapse in Human Organoids.
Journal: Journal of neurochemistry
Published: January 05, 2026
Correction: Proteomic-based stratification of intermediate-risk prostate cancer patients.
Journal: Life science alliance
Published: November 08, 2025
From bolinaquinone, a marine hydroxyquinone sesquiterpene, to naphthoquinones with clathrin inhibitory effects.
Journal: RSC medicinal chemistry
Published: October 10, 2025
Diagnosing primary ciliary dyskinesia in Australian adults: 10 years of testing.
Journal: Internal medicine journal
Published: October 10, 2025
A novel, non-invasive cnidarian venom extraction device.
Journal: Toxicon: X
Published: September 22, 2025
Proteomics-Driven Risk Stratification in Stage III Colon Cancer: A Validated Prognostic Signature for Recurrence Prediction using three independent cohorts.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 27, 2025
Proteomics-Driven Risk Stratification in Stage III Colon Cancer: A Validated Prognostic Signature for Recurrence Prediction Using Three Independent Cohorts.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 27, 2025
Last Updated: 09/26/2026